Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s473437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Puhua Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, School of Medicine, Hubei Polytechnic University, Huangshi, People's Republic …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Acetophenones, Drug Screening Assays, Antitumor, Pyruvate Dehydrogenase Acetyl-Transferring Kinase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, School of Medicine, Hubei Polytechnic University, Huangshi, People's Republic of China.
- Cancer Centre, Faculty of Health Sciences, University of Macau, Macau, People's Republic of China.
Zitieren
APA
Wu, P., Zhang, Z., Zhou, Y., Liu, Q., Tam, K. Y., & Su, Z. (2024). Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s473437
Vancouver
Wu P, Zhang Z, Zhou Y, Liu Q, Tam KY, Su Z. Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s473437
BibTeX
@article{Wu2024,
author = {Wu, Puhua and Zhang, Zhicheng and Zhou, Yan and Liu, Quan and Tam, Kin-Yip and Su, Zhenhong},
title = {Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s473437}
}
EUVIMED